Is gene therapy the next big step in vision loss treatment?

Health & Lifestyle
244

Listen to article (english)

Translate to Spanish or other 102 languages!

An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image for illustration purposes
An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image for illustration purposes

Medical News Today

- Advertisement -

An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image credit: Liliya Rodnikova/Stocksy.

Gene therapy uses genetic material, either DNA or RNA, to treat or prevent the progression of a disease. It often involves the introduction of genetic material into a person’s cells to replace a defective or missing gene. 

Although early attempts at gene therapy have been effective in achieving the expression of the therapeutic gene in the target tissue, they have also been accompanied by severe adverse effects.

- Advertisement -

Follow the link below to Medical News Today to read he full story:

https://www.medicalnewstoday.com/articles/is-gene-therapy-the-next-big-step-in-vision-loss-treatment?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-01&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS Children’s Shares Prevention Season as RSV Season Heats Up!
Next article
Volume 4 of the Mental Wellness Resource Guide Unveiled

More Articles

Lab-Grown Mini Organs Show Promise in Predicting Breast Cancer Treatment Outcomes

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors. 

STHS Hosting Community Blood Drive Amid National Blood Shortage, August 21st 

The United States is facing a severe blood shortage, prompting the American Red Cross to issue only the second national blood crisis declaration in its history.

Study Points to High Blood Pressure as a Key Factor in Rising Heart Disease Rates

Heart disease is the leading cause of death in the United States according to the Journal of the American College of Cardiology. Its impact extends beyond biology, with social detriments such as food insecurity, socioeconomic status and education influencing outcomes.

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.
- Advertisement -